{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:42:01Z","timestamp":1791204121441,"version":"4.2.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071718"],"award-info":[{"award-number":["82071718"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2021MH391"],"award-info":[{"award-number":["ZR2021MH391"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2703502"],"award-info":[{"award-number":["2022YFC2703502"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AJOG Global Reports"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.xagr.2025.100461","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T07:11:49Z","timestamp":1740208309000},"page":"100461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of different combinations of serum antim\u00fcllerian hormone levels and body mass index on pregnancy outcomes in women with polycystic ovary syndrome"],"prefix":"10.1016","volume":"5","author":[{"given":"Yue","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruolan","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gege","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3455-2984","authenticated-orcid":false,"given":"Daimin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xagr.2025.100461_bib0001","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xagr.2025.100461_bib0002","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1210\/jc.2003-030727","article-title":"Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest","volume":"88","author":"Pigny","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xagr.2025.100461_bib0003","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/09513590.2017.1381838","article-title":"Relationship between serum anti-Mullerian hormone and intrafollicular AMH levels in PCOS women","volume":"34","author":"Stracquadanio","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.xagr.2025.100461_bib0004","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.fertnstert.2009.11.002","article-title":"Serum antiMullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS)","volume":"94","author":"Hart","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xagr.2025.100461_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2011.03.047","article-title":"Follicle-stimulating hormone suppressed excessive production of antiMullerian hormone caused by abnormally enhanced promoter activity in polycystic ovary syndrome granulosa cells","volume":"95","author":"Li","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xagr.2025.100461_bib0006","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-Mullerian hormone in women","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.xagr.2025.100461_bib0007","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"120","author":"Teede","year":"2023","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xagr.2025.100461_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.01.001","article-title":"Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies","volume":"35","author":"Sanchez-Garrido","year":"2020","journal-title":"Mol Metab"},{"key":"10.1016\/j.xagr.2025.100461_bib0009","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/humrep\/des232","article-title":"Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria","volume":"27","author":"Yildiz","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xagr.2025.100461_bib0010","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.2174\/1381612822666160719105808","article-title":"Advances in the diagnosis and treatment of PCOS","volume":"22","author":"Carmina","year":"2016","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.xagr.2025.100461_bib0011","doi-asserted-by":"crossref","first-page":"E238","DOI":"10.1152\/ajpendo.90684.2008","article-title":"Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels","volume":"296","author":"Piouka","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.xagr.2025.100461_bib0012","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12884-022-04518-0","article-title":"Association of antiM\u00fcllerian hormone with polycystic ovarian syndrome phenotypes and pregnancy outcomes of in vitro fertilization cycles with fresh embryo transfer","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.xagr.2025.100461_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.02.026","article-title":"Characterization of women with elevated antiM\u00fcllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes","volume":"211","author":"Tal","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2025.100461_bib0014","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12958-020-00581-4","article-title":"High serum antiMullerian hormone levels are associated with lower live birth rates in women with polycystic ovarian syndrome undergoing assisted reproductive technology","volume":"18","author":"Tal","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.xagr.2025.100461_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2019.09.039","article-title":"High antiM\u00fcllerian hormone levels are associated with preterm delivery in patients with polycystic ovary syndrome","volume":"113","author":"Hu","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xagr.2025.100461_bib0016","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1210\/jc.2018-01320","article-title":"M\u00fcllerian-inhibiting substance\/anti-M\u00fcllerian hormone as a predictor of preterm birth in polycystic ovary syndrome","volume":"103","author":"Hsu","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xagr.2025.100461_bib0017","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/humrep\/dem254","article-title":"Serum anti-M\u00fcllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles","volume":"23","author":"Lee","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xagr.2025.100461_bib0018","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/humupd\/dmw027","article-title":"Catteau-Jonard S. Interactions between androgens, FSH, anti-M\u00fcllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary","volume":"22","author":"Dewailly","year":"2016","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.xagr.2025.100461_bib0019","article-title":"Factors associated with ovarian hyperstimulation syndrome (OHSS) severity in women with polycystic ovary syndrome undergoing IVF\/ICSI","volume":"11","author":"Sun","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.xagr.2025.100461_bib0020","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1007\/s12325-023-02582-2","article-title":"Dose nomogram of individualization of the initial follicle-stimulating hormone dosage for patients with polycystic ovary syndrome undergoing IVF\/ICSI with the GnRH-ant protocol: a retrospective cohort study","volume":"40","author":"Si","year":"2023","journal-title":"Adv Ther"},{"key":"10.1016\/j.xagr.2025.100461_bib0021","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1055\/s-0032-1328878","article-title":"Obesity and PCOS: implications for diagnosis and treatment","volume":"30","author":"Legro","year":"2012","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.xagr.2025.100461_bib0022","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6434080","article-title":"Association between body mass index and reproductive outcome in women with polycystic ovary syndrome receiving IVF\/ICSI-ET","volume":"2020","author":"Zhou","year":"2020","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.xagr.2025.100461_bib0023","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10815-016-0830-1","article-title":"Effect of body mass index on the outcomes of controlled ovarian hyperstimulation in Chinese women with polycystic ovary syndrome: a multicenter, prospective, observational study","volume":"34","author":"Sheng","year":"2017","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.xagr.2025.100461_bib0024","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejogrb.2011.06.006","article-title":"Is the plasma anti-M\u00fcllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?","volume":"158","author":"Ska\u0142ba","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.xagr.2025.100461_bib0025","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00404-018-4803-8","article-title":"The diagnosis of PCOS in young infertile women according to different diagnostic criteria: the role of serum anti-M\u00fcllerian hormone","volume":"298","author":"Casadei","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.xagr.2025.100461_bib0026","first-page":"179","article-title":"Impact of body mass index and vitamin D on serum AMH levels and antral follicle count in PCOS","volume":"27","author":"Dokuzeyl\u00fcl G\u00fcng\u00f6r","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.xagr.2025.100461_bib0027","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12958-023-01064-y","article-title":"The reference value of anti-M\u00fcllerian hormone to diagnose polycystic ovary syndrome is inversely associated with BMI: a retrospective study","volume":"21","author":"Zhang","year":"2023","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.xagr.2025.100461_bib0028","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.fertnstert.2020.07.023","article-title":"A patient-specific model combining antiM\u00fcllerian hormone and body mass index as a predictor of polycystic ovary syndrome and other oligo-anovulation disorders","volume":"115","author":"Vagios","year":"2021","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xagr.2025.100461_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2014.03.032","article-title":"Age-specific serum antiM\u00fcllerian hormone levels in women with and without polycystic ovary syndrome","volume":"102","author":"Cui","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xagr.2025.100461_bib0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-981-15-1792-1_8","article-title":"Exercise and polycystic ovary syndrome","volume":"1228","author":"Woodward","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.xagr.2025.100461_bib0031","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/humupd\/8.6.559","article-title":"Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review","volume":"8","author":"Delvigne","year":"2002","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.xagr.2025.100461_bib0032","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/humrep\/deac210","article-title":"Polycystic ovary syndrome and risk of adverse pregnancy outcomes: a registry linkage study from Massachusetts","volume":"37","author":"Farland","year":"2022","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xagr.2025.100461_bib0033","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.rbmo.2019.03.203","article-title":"A meta-analysis of pregnancy-related outcomes and complications in women with polycystic ovary syndrome undergoing IVF","volume":"39","author":"Sha","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.xagr.2025.100461_bib0034","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/humupd\/dmv029","article-title":"Pregnancy complications in women with polycystic ovary syndrome","volume":"21","author":"Palomba","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.xagr.2025.100461_bib0035","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1513873","article-title":"Fresh versus Frozen Embryos for Infertility in the polycystic ovary syndrome","volume":"375","author":"Chen","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xagr.2025.100461_bib0036","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1745-6215-15-154","article-title":"Live birth after fresh embryo transfer vs elective embryo cryopreservation\/frozen embryo transfer in women with polycystic ovary syndrome undergoing IVF (FreFro-PCOS): study protocol for a multicenter, prospective, randomized controlled clinical trial","volume":"15","author":"Shi","year":"2014","journal-title":"Trials"},{"key":"10.1016\/j.xagr.2025.100461_bib0037","first-page":"83","article-title":"Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults\u2014study on optimal cut-off points of body mass index and waist circumference in Chinese adults","volume":"15","author":"Zhou","year":"2002","journal-title":"Biomed Environ Sci"},{"key":"10.1016\/j.xagr.2025.100461_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.788000","article-title":"Elevated anti-M\u00fcllerian hormone is an independent risk factor for preterm birth among patients with overweight polycystic ovary syndrome","volume":"12","author":"Du","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.xagr.2025.100461_bib0039","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jc.2003-030932","article-title":"Anti-M\u00fcllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age","volume":"89","author":"Laven","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xagr.2025.100461_bib0040","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.fertnstert.2005.10.054","article-title":"Obesity and androgens: facts and perspectives","volume":"85","author":"Pasquali","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xagr.2025.100461_bib0041","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/oxfordjournals.humrep.a137638","article-title":"Granulosa cells of polycystic ovaries: are they normal or abnormal?","volume":"7","author":"Erickson","year":"1992","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xagr.2025.100461_bib0042","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2265.1996.724545.x","article-title":"Functional integrity of granulosa cells from polycystic ovaries","volume":"44","author":"Almahbobi","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.xagr.2025.100461_bib0043","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1159\/000373961","article-title":"AMH and AMHR2 polymorphisms and AMH serum level can predict assisted reproduction outcomes: a cross-sectional study","volume":"35","author":"Peluso","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.xagr.2025.100461_bib0044","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/0974-1208.153120","article-title":"Revisiting ovarian hyper stimulation syndrome: towards OHSS free clinic","volume":"8","author":"Banker","year":"2015","journal-title":"J Hum Reprod Sci"},{"key":"10.1016\/j.xagr.2025.100461_bib0045","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00404-021-06124-5","article-title":"The influence of obesity on incidence of complications in patients hospitalized with ovarian hyperstimulation syndrome","volume":"305","author":"Mandelbaum","year":"2022","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.xagr.2025.100461_bib0046","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humrep\/17.1.107","article-title":"Increased early pregnancy loss in IVF patients with severe ovarian hyperstimulation syndrome","volume":"17","author":"Raziel","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xagr.2025.100461_bib0047","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/humrep\/deh638","article-title":"Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile","volume":"20","author":"Papanikolaou","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xagr.2025.100461_bib0048","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.fertnstert.2020.04.004","article-title":"Ovarian hyperstimulation syndrome after assisted reproductive technologies: trends, predictors, and pregnancy outcomes","volume":"114","author":"Schirmer","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xagr.2025.100461_bib0049","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1210\/endrev\/bnab012","article-title":"Anti-M\u00fcllerian hormone in female reproduction","volume":"42","author":"di Clemente","year":"2021","journal-title":"Endocr Rev"},{"key":"10.1016\/j.xagr.2025.100461_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2014.09.041","article-title":"AntiM\u00fcllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis","volume":"103","author":"Tal","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xagr.2025.100461_bib0051","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12958-023-01087-5","article-title":"AMH predicts miscarriage in non-PCOS but not in PCOS related infertility ART cycles","volume":"21","author":"Arkfeld","year":"2023","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.xagr.2025.100461_bib0052","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","article-title":"Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)","volume":"16","author":"La Marca","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.xagr.2025.100461_bib0053","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12967-016-0924-7","article-title":"Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH","volume":"14","author":"Gleicher","year":"2016","journal-title":"J Transl Med"},{"key":"10.1016\/j.xagr.2025.100461_bib0054","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12884-022-04591-5","article-title":"Serum anti-M\u00fcllerian hormone levels are associated with early miscarriage in the IVF\/ICSI fresh cycle","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.xagr.2025.100461_bib0055","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.592495","article-title":"High BMI and insulin resistance are risk factors for spontaneous abortion in patients with polycystic ovary syndrome undergoing assisted reproductive treatment: a systematic review and meta-analysis","volume":"11","author":"Sun","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.xagr.2025.100461_bib0056","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.fertnstert.2019.08.009","article-title":"Effect of body mass index on pregnancy outcomes with the freeze-all strategy in women with polycystic ovarian syndrome","volume":"112","author":"Qiu","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xagr.2025.100461_bib0057","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/humrep\/den017","article-title":"High and low BMI increase the risk of miscarriage after IVF\/ICSI and FET","volume":"23","author":"Veleva","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xagr.2025.100461_bib0058","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.rbmo.2022.10.002","article-title":"Risk factors for clinical pregnancy loss after IVF in women with PCOS","volume":"46","author":"Wang","year":"2023","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.xagr.2025.100461_bib0059","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12958-018-0336-z","article-title":"Obesity as disruptor of the female fertility","volume":"16","author":"Silvestris","year":"2018","journal-title":"Reprod Biol Endocrinol"}],"container-title":["AJOG Global Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266657782500022X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266657782500022X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T21:57:04Z","timestamp":1762639024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266657782500022X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S266657782500022X"],"URL":"https:\/\/doi.org\/10.1016\/j.xagr.2025.100461","relation":{},"ISSN":["2666-5778"],"issn-type":[{"value":"2666-5778","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of different combinations of serum antim\u00fcllerian hormone levels and body mass index on pregnancy outcomes in women with polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"AJOG Global Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xagr.2025.100461","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100461"}}